Subcutaneous injection of yeast microparticles containing an IDO1 siRNA was able to significantly delay melanoma tumor growth in vivo, compared to yeast loaded with only TRP2 peptides or IDO1 siRNA, suggesting a strong synergistic effect of the siRNA and TRP2 antigen. This evidence concerns the gene DCT and melanoma.